{"id":"propionyl-l-carnitine-tablets","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Gastrointestinal disorders"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Propionyl-L-carnitine is thought to exert its effects by increasing the levels of L-carnitine in the body, which can help to improve blood flow and reduce oxidative stress. This may be beneficial for conditions such as intermittent claudication and erectile dysfunction.","oneSentence":"Propionyl-L-carnitine is a carnitine derivative that may improve blood flow and reduce oxidative stress.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:32.230Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Intercritical and progressive forms of multiple sclerosis"},{"name":"Atherosclerosis"},{"name":"Erectile dysfunction"},{"name":"Intermittent claudication"}]},"trialDetails":[{"nctId":"NCT01026857","phase":"PHASE2","title":"Propionyl-L-Carnitine in Ulcerative Colitis","status":"COMPLETED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2006-05","conditions":"Ulcerative Colitis","enrollment":121},{"nctId":"NCT01567956","phase":"PHASE3","title":"Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerability Study","status":"TERMINATED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2012-04","conditions":"Ulcerative Colitis","enrollment":150},{"nctId":"NCT01538251","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis","status":"TERMINATED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2012-04","conditions":"Ulcerative Colitis","enrollment":147},{"nctId":"NCT02786069","phase":"PHASE1","title":"A Single-dose Escalation Safety and PK Study for PLC in Healthy Chinese","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2015-06","conditions":"Peripheral Arterial Disease","enrollment":16},{"nctId":"NCT00809497","phase":"PHASE3","title":"A Clinical Study on Efficacy & Safety Profile of Propionyl-L-carnitine Tablets for Peripheral Arterial Diseases","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2008-05","conditions":"Peripheral Arterial Disease","enrollment":239}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["DROMOS, ST261"],"phase":"phase_3","status":"active","brandName":"Propionyl-L-carnitine Tablets","genericName":"Propionyl-L-carnitine Tablets","companyName":"Lee's Pharmaceutical Limited","companyId":"lee-s-pharmaceutical-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Propionyl-L-carnitine is a carnitine derivative that may improve blood flow and reduce oxidative stress. Used for Intercritical and progressive forms of multiple sclerosis, Atherosclerosis, Erectile dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}